Basic approach on the protective effects of hesperidin and naringin in Alzheimer's disease

被引:0
|
作者
Kusi, Muejgan [1 ,2 ]
Becer, Eda [3 ]
Vatansever, Hafize Seda [4 ,5 ]
机构
[1] Near East Univ, Fac Hlth Sci, Dept Nutr & Dietet, Via Mersin 10, Nicosia, N Cyprus, Turkiye
[2] Near East Univ, Res Ctr Sci Technol & Engn BILTEM, Via Mersin 10, Nicosia, N Cyprus, Turkiye
[3] Eastern Mediterranean Univ, Fac Pharm, Via Mersin 10, Famagusta, N Cyprus, Turkiye
[4] Near East Univ, DESAM Inst, Via Mersin 10, Nicosia, N Cyprus, Turkiye
[5] Manisa Celal Bayar Univ, Fac Med, Dept Histol & Embryol, Manisa, Turkiye
关键词
Alzheimer's disease; hesperidin; naringin; neuroprotective effect; oxidative stress; inflammation; A beta aggregation; antiapoptotic effect; INDUCED COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; ORANGE JUICE; MITOCHONDRIAL DYSFUNCTION; EXPERIMENTAL PARADIGM; CEREBROSPINAL-FLUID; CITRUS FLAVANONES; INDUCED APOPTOSIS; MOUSE MODEL;
D O I
10.1080/1028415X.2024.2397136
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
ObjectivesAlzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive impairment. This situation imposes a great burden on individuals, both economically and socially. Today, an effective method for treating the disease and protective approach to tau accumulation has not been developed yet. Studies have been conducted on the effects of hesperidin and naringin flavonoids found in citrus fruits on many diseases.MethodsIn this review, the pathophysiology of AD is defined, and the effects of hesperidin and naringin on these factors are summarized.ResultsStudies have shown that both components may potentially affect AD due to their antioxidative and anti-inflammatory properties. Based on these effects of the components, it has been shown that they may have ameliorative effects on A beta, alpha-synuclein aggregation, tau pathology, and cognitive functions in the pathophysiology of AD.DiscussionThere are studies suggesting that hesperidin and naringin may be effective in the prevention/treatment of AD. When these studies are examined, it is seen that more studies should be conducted on the subject.
引用
收藏
页码:550 / 562
页数:13
相关论文
共 50 条
  • [1] Naringin and Naringenin: Potential Multi-Target Agents for Alzheimer's Disease
    Lu, Jing
    Chen, Jie
    Li, Shu-yue
    Pan, Guang-jie
    Ou, Yi
    Yuan, Li-fu
    Jiang, Jian-ping
    Zeng, Ling-hui
    Zhao, Jie
    CURRENT MEDICAL SCIENCE, 2024, 44 (05) : 867 - 882
  • [2] Neuroprotective Effects of Hesperidin and Naringin in SK-N-AS Cell as an In Vitro Model for Alzheimer's Disease
    Kusi, Mujgan
    Becer, Eda
    Vatansever, Hafize Seda
    Yucecan, Sevinc
    JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION, 2023, 42 (04): : 418 - 426
  • [3] Efficacy and molecular mechanisms of hesperidin in mitigating Alzheimer's disease: A systematic review
    Han, Xu
    Zhang, Yuting
    Zhang, Lijuan
    Zhuang, Yanyan
    Wang, Yu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 283
  • [4] A Review on the Protective Effects of Probiotics against Alzheimer's Disease
    Mishra, Vibhuti
    Yadav, Dhananjay
    Solanki, Kavita Singh
    Koul, Bhupendra
    Song, Minseok
    BIOLOGY-BASEL, 2024, 13 (01):
  • [5] Protective Effects of Liquiritin on the Brain of Rats with Alzheimer's Disease
    Huang, X.
    Wang, Y.
    Ren, K.
    WEST INDIAN MEDICAL JOURNAL, 2015, 64 (05): : 468 - 472
  • [6] Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer's Disease-like Pathology: A Comprehensive Review
    Singh, Ashini
    Singh, Niraj Kumar
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (09) : 1112 - 1123
  • [7] Dapagliflozin/Hesperidin Combination Mitigates Lipopolysaccharide-Induced Alzheimer's Disease in Rats
    Abd Elmaaboud, Maaly A.
    Estfanous, Remon S.
    Atef, Aliaa
    Kabel, Ahmed M.
    Alnemari, Khalid A.
    Naguib, Tamer M.
    Alsufyani, Shuruq E.
    Darwish, Hany W.
    Arab, Hany H.
    PHARMACEUTICALS, 2023, 16 (10)
  • [8] Neurofibrillary Tangle Formation as a Protective Response to Oxidative Stress in Alzheimer's Disease
    Nunomura, Akihiko
    Takeda, Atsushi
    Moreira, Paula I.
    Castellani, Rudy J.
    Lee, Hyoung-gon
    Zhu, Xiongwei
    Smith, Mark A.
    Perry, George
    CURRENT HYPOTHESES AND RESEARCH MILESTONES IN ALZHEIMER'S DISEASE, 2009, : 103 - 113
  • [9] Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease
    Abdelhamid, Mona
    Counts, Scott E.
    Zhou, Chunyu
    Hida, Hideki
    Kim, Jae-Il
    Michikawa, Makoto
    Jung, Cha-Gyun
    NUTRIENTS, 2025, 17 (03)
  • [10] N,N′-1,10-Bis(Naringin) Triethylenetetraamine, Synthesis and as a Cu(II) Chelator for Alzheimer's Disease Therapy
    Guo, Li-Xia
    Sun, Bin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (01) : 51 - 56